In contrast, sustained p-Erk and p-Akt was observed in a number of FLT3-WT AML samples at 15′ compared to healthy BMMb (Table 3) and elevated signaling was evident at earlier timepoints (Figure 2). This evidence concerns the gene FLT3 and acute myeloid leukemia.